Shennon Biotechnologies

Shennon Biotechnologies is a San Francisco based biotechnology company accelerating drug development by screening millions of single cell-cell interactions to identify novel therapeutic agents for cancer and autoimmune disease. Its proprietary TCELERATOR platform combines ultrafast single cell-cell interaction mapping with proprietary AI models to discover new targets and develop more effective medicines. The company is backed by DCVC and, as of this enrichment pass, publishes a corporate marketing site but no public API, developer portal, SDK, or machine-readable interface.

Shennon Biotechnologies is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Drug Discovery, Artificial Intelligence, and Immunology.

5.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyDrug DiscoveryArtificial IntelligenceImmunologyOncologySingle CellLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 5.0/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 1.8 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 0.8 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/shennon-biotechnologies: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Operate 1

Status, limits, changes, and where to get help

Commercial 1

Pricing, plans, and the legal terms of use

Company 3

The organization behind the API

Other 2

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: shennon-biotechnologies
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/shennon-biotechnologies.png
name: Shennon Biotechnologies
description: Shennon Biotechnologies is a San Francisco based biotechnology company accelerating drug development by screening
  millions of single cell-cell interactions to identify novel therapeutic agents for cancer and autoimmune disease. Its proprietary
  TCELERATOR platform combines ultrafast single cell-cell interaction mapping with proprietary AI models to discover new targets
  and develop more effective medicines. The company is backed by DCVC and, as of this enrichment pass, publishes a corporate
  marketing site but no public API, developer portal, SDK, or machine-readable interface.
url: https://raw.githubusercontent.com/api-evangelist/shennon-biotechnologies/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Drug Discovery
- Artificial Intelligence
- Immunology
- Oncology
- Single Cell
- Life Sciences
apis: []
common:
- type: Website
  url: https://shennonbio.com
- type: Team
  url: https://shennonbio.com/team
- type: Technology
  url: https://shennonbio.com/technology
- type: Careers
  url: https://shennonbio.com/careers
- type: Contact
  url: https://shennonbio.com/contact-us
- type: PrivacyPolicy
  url: https://shennonbio.com/privacy-policy
- type: LinkedIn
  url: https://www.linkedin.com/company/shennon-bio/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 0
  pass: local-v1